What is 503B Outsourcing Facility?
FDA-registered compounding facility that can produce larger quantities without patient-specific prescriptions. Subject to cGMP requirements and FDA oversight.
503B outsourcing facilities register with the FDA, may compound large batches for office use without patient-specific prescriptions, and are held to current Good Manufacturing Practice (cGMP) — a substantially higher bar than USP compounding chapters alone. They are inspected by the FDA on a risk-based schedule.
Because cGMP expects batch records, validated processes, environmental monitoring programs, and formal quality units, 503B facilities typically need more rigorous record systems than 503A pharmacies, including release testing documentation and deviation/CAPA programs with full traceability.
See how CompliRx handles this in practice:
503B compliance softwareRelated terms
Turn the standard into daily records
CompliRx helps compounding pharmacies keep environmental monitoring, qualifications, cleaning, documents, and CAPA evidence inspection-ready.